Document Detail

MAT-CHDSP, a novel medication assessment tool for evaluation of secondary prevention of coronary heart disease.
MedLine Citation:
PMID:  21351306     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Quality of health performance is of increasing international importance. The potential value of the implementation of a guideline-based medication assessment tool (MAT) has been evaluated in order to measure and improve adherence to guideline recommendations in secondary prevention of coronary heart disease (CHD).
METHOD: An existing MAT developed in the UK based on internationally recognised clinical evidence has been further developed [with criteria extended to secondary prevention of CHD only] for application in Norway. Content validity was demonstrated using a two round Delphi process among an expert group (12 reviewers, consensus threshold 75%). Inter- and intra-observer reliability testing was conducted with agreement expressed by Cohen's kappa (κ). The designed MAT was applied in a pilot study and application time was measured to inform clinical utility of the tool in real world settings. A total of 85 patients (69% male) undergoing coronary angiography were included. Mean age was 65.4 years (SD 11.6).
RESULTS: The new MAT is named MAT-CHDSP and comprises 21 review criteria. Consensus among the expert group (n = 12) was obtained for all final criteria. Reliability testing showed κ in the range (0.79-0.90). Applicability in the pilot study was 63% (n = 1106) and adherence was 65%, 95% CI (64-66) (n = 791). The mean application time for the experienced user was 1.5 minutes (SD 0.3).
CONCLUSION: MAT methodology might merge the increasing demand for continuous assessment of quality of health performance with the clinical pharmacist's need for a standardised and explicit working tool. Copyright © 2010 John Wiley & Sons, Ltd.
Beate Hennie Garcia; June Utnes; Liv Unni Naalsund; Trude Giverhaug
Related Documents :
19276816 - Pedicled superficial temporal fascia sandwich flap for reconstruction of severe facial ...
21390406 - Screening tools for postpartum depression: validity and cultural dimensions.
21324146 - The psychological context of quality of life: a psychometric analysis of a novel idiogr...
21464896 - A social network analysis of treatment discoveries in cancer.
20434606 - A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on...
1847796 - Colectomy, mucosal proctectomy, and ileal pouch-anal anastomosis. a prospective trial o...
Publication Detail:
Type:  Journal Article     Date:  2010-12-23
Journal Detail:
Title:  Pharmacoepidemiology and drug safety     Volume:  20     ISSN:  1099-1557     ISO Abbreviation:  Pharmacoepidemiol Drug Saf     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-02-25     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9208369     Medline TA:  Pharmacoepidemiol Drug Saf     Country:  England    
Other Details:
Languages:  eng     Pagination:  249-57     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 John Wiley & Sons, Ltd.
Hospital Pharmacy of North Norway Trust, Tromsø, Norway; Department of Pharmacy, Faculty of Health Science, University of Tromsø, Tromsø, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medici...
Next Document:  Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database.